You are here

  • Home
  • Archive
  • Volume 20, Issue Suppl 1
  • CPC-105 Pharmacoeconomic Aspects of the Treatment of Rheumatoid Arthritis with Tumour Necrosis Factor Alpha Antagonists: A Societal Perspective

Article info

Article menu

Download PDFPDF

Clinical pharmacy and clinical trials (including case series)
CPC-105 Pharmacoeconomic Aspects of the Treatment of Rheumatoid Arthritis with Tumour Necrosis Factor Alpha Antagonists: A Societal Perspective
Free

Authors

Citation

Marongiu C, Francisco C, Modena V, et al
CPC-105 Pharmacoeconomic Aspects of the Treatment of Rheumatoid Arthritis with Tumour Necrosis Factor Alpha Antagonists: A Societal Perspective
European Journal of Hospital Pharmacy 2013;20:A202-A203.

Publication history

  • First published March 12, 2013.
Online issue publication 
October 20, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions